ImageneBio Financials - Benzinga

ImageneBio Inc

IMANASDAQ

Trade with Public

Trade with Public

$5.34

0.010.19%

At close: Aug 28, 5:00 PM EST

$5.55

0.213.93%

After Hours: Aug 25, 4:23 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Stock Report

ImageneBio Financials

ImageneBio (IMA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
ImageneBio Q2 EPS $(0.63) Beats $(1.05) Estimate

ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(1.05) by 40 percent.

Benzinga Newsdesk

PRO
ImageneBio Q1 EPS $(0.95) Misses $(0.70) Estimate

ImageneBio (NASDAQ:IMA) reported quarterly losses of $(0.95) per share which missed the analyst consensus estimate of $(0.70) by 35.71 percent.

Benzinga Newsdesk

PRO
ImageneBio Q4 EPS $(6.73) Misses $(1.44) Estimate

ImageneBio (NASDAQ:IMA) reported quarterly losses of $(6.73) per share which missed the analyst consensus estimate of $(1.44) by 368.34 percent.

Benzinga Newsdesk

PRO
ImageneBio Q3 EPS $(2.91) Misses $(1.28) Estimate

ImageneBio (NASDAQ:IMA) reported quarterly losses of $(2.91) per share which missed the analyst consensus estimate of $(1.28) by 127.34 percent. This is a 12.79 percent decrease over losses of $(2.58) per share from the

Benzinga Newsdesk